David J Mazzo insider trades
Open-market stock purchases and sales by David J Mazzo, President & CEO at Lisata Therapeutics, Inc, from SEC Form 4 filings since Feb 18, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 9, 2026 | LSTA Lisata Therapeutics, Inc | Bought (not open market) | — |
| Jan 9, 2026 | LSTA Lisata Therapeutics, Inc | Sold (not open market) | $24.1K |
| Jan 9, 2026 | LSTA Lisata Therapeutics, Inc | Sold (not open market) | $15.5K |
| Jan 9, 2026 | LSTA Lisata Therapeutics, Inc | Bought (not open market) | — |
| Jan 9, 2026 | LSTA Lisata Therapeutics, Inc | Sold (not open market) | $20.7K |
| Jan 9, 2026 | LSTA Lisata Therapeutics, Inc | Sold (not open market) | $20.7K |
Companies traded
- LSTA Lisata Therapeutics, Inc: other filings, last Jan 9, 2026
- CLBS Caladrius Biosciences, Inc: 1 buy, last Sep 1, 2022
- SNCA Seneca Biopharma, Inc: other filings, last Apr 1, 2021
- EYPT EyePoint Pharmaceuticals, Inc: other filings, last Feb 28, 2020
- CUR Neuralstem, Inc: other filings, last Jul 1, 2019
- PSDV pSivida Corp: other filings, last Dec 15, 2017
- NBS NeoStem, Inc: other filings, last Jun 2, 2015
- AVNR Avanir Pharmaceuticals, Inc: other filings, last Feb 12, 2014
- RGDO Regado Biosciences Inc: other filings, last Jan 1, 2014